Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Mazzocca

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|May 29, 2012
The TGF-β signaling pathway as a pharmacological target in a hepatocellular carcinomaAntonio Mazzocca, Salvatore Antonaci, Gianluigi Giannelli
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|July 13, 2022
The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic CancerDavide Gnocchi, Carlo Sabbà, Antonio Mazzocca
Journal of Clinical Medicine|April 23, 2022
Chronic Inflammation in Obesity and Cancer CachexiaRosa Divella, Gennaro Gadaleta Caldarola, Antonio Mazzocca
Oncogene|December 17, 2003
Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cellsVinicio Carloni, Antonio Mazzocca, Kodimangalam S Ravichandran
Hepatology (Baltimore, Md.)|December 31, 2008
Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinomaEmilia Fransvea, Antonio Mazzocca, Salvatore Antonaci, et al.
International Journal of Molecular Sciences|January 8, 2023
The Adaptability of Chromosomal Instability in Cancer Therapy and ResistanceVinicio Carloni, Elisa Morganti, Andrea Galli, et al.
Clinical & Developmental Immunology|November 3, 2011
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumorsFrancesco Dituri, Antonio Mazzocca, Gianluigi Giannelli, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 7, 2019
Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiologyDavide Gnocchi, Carlo Custodero, Carlo Sabbà, et al.
Medical Hypotheses|November 7, 2018
Moving the systemic evolutionary approach to cancer forward: Therapeutic implicationsAntonio Mazzocca, Giovanni Ferraro, Giovanni Misciagna, et al.
International Journal of Molecular Sciences|February 25, 2023
Metabolism as a New Avenue for Hepatocellular Carcinoma TherapyDavide Gnocchi, Carlo Sabbà, Mara Massimi, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|May 29, 2012
The TGF-β signaling pathway as a pharmacological target in a hepatocellular carcinomaAntonio Mazzocca, Salvatore Antonaci, Gianluigi Giannelli
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|July 13, 2022
The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic CancerDavide Gnocchi, Carlo Sabbà, Antonio Mazzocca
Journal of Clinical Medicine|April 23, 2022
Chronic Inflammation in Obesity and Cancer CachexiaRosa Divella, Gennaro Gadaleta Caldarola, Antonio Mazzocca
Oncogene|December 17, 2003
Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cellsVinicio Carloni, Antonio Mazzocca, Kodimangalam S Ravichandran
Hepatology (Baltimore, Md.)|December 31, 2008
Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinomaEmilia Fransvea, Antonio Mazzocca, Salvatore Antonaci, et al.
International Journal of Molecular Sciences|January 8, 2023
The Adaptability of Chromosomal Instability in Cancer Therapy and ResistanceVinicio Carloni, Elisa Morganti, Andrea Galli, et al.
Clinical & Developmental Immunology|November 3, 2011
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumorsFrancesco Dituri, Antonio Mazzocca, Gianluigi Giannelli, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 7, 2019
Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiologyDavide Gnocchi, Carlo Custodero, Carlo Sabbà, et al.
Medical Hypotheses|November 7, 2018
Moving the systemic evolutionary approach to cancer forward: Therapeutic implicationsAntonio Mazzocca, Giovanni Ferraro, Giovanni Misciagna, et al.
International Journal of Molecular Sciences|February 25, 2023
Metabolism as a New Avenue for Hepatocellular Carcinoma TherapyDavide Gnocchi, Carlo Sabbà, Mara Massimi, et al.
Pageof 7